Anne Wojcicki
Anne Wojcicki Wiki | |
---|---|
Name | Anne Wojcicki |
Profession | Entrepreneur |
Age | 51 years |
Date of Birth | July 28, 1973 |
Horoscope | Leo |
Country | United States |
Height | Check Below |
Net Worth | See Below |
Birthday Countdown
Early Life and Education
Anne Wojcicki was born on July 28, 1973, in San Mateo County, California. She is the youngest of three daughters born to Esther Wojcicki, a renowned educator and journalist, and Stanley Wojcicki, a physics professor at Stanford University. Anne grew up in Palo Alto and attended Gunn High School. She went on to study biology at Yale University, where she graduated with honors in 1996.
Career
After graduating from Yale, Anne worked as a healthcare consultant at Investor AB. In 2006, she co-founded 23andMe, a direct-to-consumer genetic testing company. Under her leadership, the company has grown to become one of the leading providers of personalized genetic testing services. Anne is known for her advocacy of consumer access to genetic information and has been a vocal proponent of personalized medicine.
In addition to her work at 23andMe, Anne has also been involved in various philanthropic endeavors. She co-founded the Breakthrough Prize in Life Sciences, which awards $3 million annually to researchers who have made significant contributions to the field of life sciences.
Age and Height
Anne Wojcicki is currently 50 years old and stands at a height of 5 feet 9 inches.
Net Worth
As of 2024, Anne Wojcicki's net worth is estimated to be around $1 billion. Much of her wealth comes from her stake in 23andMe, which has been valued at over $2 billion.
Personal Life
In 2007, Anne married Google co-founder Sergey Brin. The couple has two children together but divorced in 2015. Anne is known for her active lifestyle and passion for outdoor activities such as hiking and skiing.
Conclusion
Anne Wojcicki is a prominent figure in the field of genetics and personalized medicine. Her work at 23andMe has revolutionized the way we think about genetic testing and has paved the way for advancements in personalized healthcare. With her continued dedication to innovation and advocacy, Anne is sure to remain a key player in the world of biotechnology for years to come.